Skip to main content
. 2017 Sep 27;174(1):35–44. doi: 10.1159/000478699

Fig. 2.

Fig. 2

Forest plot of hazard ratio for subjects with moderate or severe treatment-related adverse events in various subgroups (MT-04 + MT-06 full analysis set). GINA step subgroups include subjects based on level of asthma medication at screening. Mono-sensitised includes subjects sensitised to house dust mite (HDM) only; poly-sensitised includes subjects sensitised to other allergens in addition to HDM. Plc-Act, placebo-active.